Seòmar agus comataidhean

The Scottish Government recognises that long waits are unacceptable, and remains committed to meeting the standard that 90% of patients begin treatment within 18 weeks of referral.

We have asked all Boards, including NHS Grampian, to set out their plans and trajectories for meeting the waiting times standards and clearing backlogs by the end of March 2023. To support this, we have already allocated £5m from the Mental Health Recovery and Renewal Fund, for the first year of clearing waiting list backlogs in Psychological Therapies. NHS Grampian has received £490,666 from this fund.

Nationally, we are starting to see this investment reflected in improved Psychological Therapies waiting times performance, and a decrease in the number of people waiting longest. We will continue to work closely with individual Health Boards to monitor and drive performance in mental health waiting times across Scotland.

The Scottish Government has published the Evaluation of the Scottish Strategy for Autism 2011-21 on 24 September. In response I was delighted to announce £650k this financial year, for tests of change on adult neurodevelopmental pathways. Additionally I announced new funding of £425k to trial the Scottish Government’s new Learning Disability and Autism leadership and engagement work and £400k for the understanding autism project charity funding.

The evaluation can be viewed at: https://www.gov.scot/isbn/9781802013696

The Scottish Government Chief Scientist Office (CSO) investment in NHS Research Scotland (NRS) clinical research infrastructure is supporting NHS Health Board participation in a number of COVID-19 vaccine trials to provide data for regulatory submissions for approval for use.

The CSO, NRS and health boards work closely with the UK Vaccines Taskforce to bring a range of vaccine trials to Scotland.

Regulatory approval and licensing conditions for the use of COVID-19 vaccines is a statutory responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).

More information about the trials being supported by NHS Research Scotland is available at: COVID-19 vaccine studies | NHS Research Scotland | NHS Research Scotland .

NHS Scotland are working with colleagues in some international countries to create a system that will enable them to collect the appropriate information. A range of mechanisms is currently under consideration for how this can be done most effectively and efficiently.

As part of the NHS Scotland response to coronavirus (COVID-19), an Innovation Workstream has been created to manage the evaluation of antibody and swab (PCR) tests. This workstream is led by NHS NSS and clinical scientists from NHS Health Boards, and is designed to take advantage of rapid innovations within testing, while at the same time avoiding duplication of effort between Health Boards.

As part of this workstream, antibody tests being used within Scotland are validated by NHS Scotland. The evaluation reports for the antibody assays which have currently been validated and are in use are publicly available, and can be found on NHS Scotland’s Health Innovation Assessment Portal . These evaluation reports show the high sensitivity and specificity of antibody tests approved for use within Scotland.

Scotland is also part of the UK National Testing Programme, participating in UK-wide antibody studies such as the Post Positive PCR Antibody Testing Initiative, where antibody tests have been validated by the UK Government. These validation reports are publicly available, and can be found on the UK Government website .

The Saving Scotland’s Red Squirrel project has been running since 2008. The Developing Community Action phase of the project is due to run until April 2022.

Partners have agreed that that essential elements of the community action phase will need to continue and hence partners have also agreed to develop an interim phase to bridge the gap to develop a longer term model for continuing to support these activities. NatureScot is working with partners to assess the key outcomes and costs for this interim phase, and will look to provide a funding contribution once these costs and priorities are clear.

NatureScott considers that securing the legacy of this project is a priority given the importance of red squirrels in Scotland’s native wildlife.

The Scottish Government supports the Scottish Venison Strategy and its ambition for 2030 to make Scottish Venison the premier choice of consumers and commercial buyers, both here in the UK and in international markets. We have provided funding to support a venison promotion campaign earlier this year.

I was delighted to recently support Scottish Venison Day on 4 September and I was pleased that retail sales of Scottish venison have recently increased. As part of the Food and Drink Recovery Plan, the Scotland Food and Drink Partnership has also provided £80,000 to support demonstration sites for locally based chill and processing facilities.

The Scottish Government has no plans to introduce a wild venison marketing board.

Dental services have not been stopped during the pandemic period. Dental practices were initially closed with urgent and emergency dental care provided through urgent dental care centres. Dental practices reopened following a phased remobilisation programme which culminated on 1 November with dental teams able to provide the full range of NHS care and treatment to patients. While it is the case patient numbers continue to be less than pre-pandemic - as dental teams are required to operate within strict infection, prevention and control guidance - pregnant women and nursing mothers who required urgent or emergency dental care would still be seen during the pandemic period.

The Scottish Government have previously been made aware of this issue and earlier this year investigated the it further. Our investigation established that this was a historical, localised issue in the Aberdeenshire area where they had not been applying the guidance fully. Two years ago they revised their internal processes to ensure assessments were carried out on applications made by organisations seeking a Blue Badge in compliance with Scottish Governments Blue Badge guidance.

We are currently undertaking a review of the guidance we provide to Local Authorities to improve the process for organisations applying for a Blue Badge and to make it clear and consistent across the country. We are also seeking to ensure that the online application form is more robust and provides organisations and Local Authorities with all the necessary information to elicit a more efficient process.

When disruptions occur CalMac Ferries Ltd will conduct a network wide review to minimise the impact on communities. This includes redeployment of vessels from elsewhere on the Clyde and Hebrides Ferry Services (CHFS) network, identification of an alternative ferry route when an island (or group of islands), has more than one port, and provision of additional sailings on these alternative routes.

In this instance, it included additional sailings on the Uig – Lochmaddy route allowing onward travel to Lochboisdale, with the MV Clansman redeployed to operate this service. Services on all affected routes resumed normal timetabled sailings from 10 September 2021.

CalMac Customer Operations teams moved impacted traffic from affected sailings, contacting customers advising them of suggested alternative sailing; or if the customer preferred, offer a full refund.